Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 2751–2800 of 34667
each of Michael T. Andriole, Mike Sherman, Martha J. Demski, Fred. A. Middleton, Robert J. Meyer, Marc D. Kozin, Pratik S. Multani, Vicki Vakiener and Lisa L. Decker resigned from his or her respective positions as a member of the Company’s board of directors and all committees thereof
each of Michael T. Andriole, Mike Sherman, Martha J. Demski, Fred. A. Middleton, Robert J. Meyer, Marc D. Kozin, Pratik S. Multani, Vicki Vakiener and Lisa L. Decker resigned from his or her respective positions as a member of the Company’s board of directors and all committees thereof
Alan Campion, the sole director of the Purchaser immediately prior to the Effective Time, became the sole director of the Company
each of Michael T. Andriole, Mike Sherman, Martha J. Demski, Fred. A. Middleton, Robert J. Meyer, Marc D. Kozin, Pratik S. Multani, Vicki Vakiener and Lisa L. Decker resigned from his or her respective positions as a member of the Company’s board of directors and all committees thereof
each of Michael T. Andriole, Mike Sherman, Martha J. Demski, Fred. A. Middleton, Robert J. Meyer, Marc D. Kozin, Pratik S. Multani, Vicki Vakiener and Lisa L. Decker resigned from his or her respective positions as a member of the Company’s board of directors and all committees thereof
The effective date of appointment of Mr. Galligan is April 22, 2025.
The effective date of appointment of Messrs. Mohamed and Burns is April 15, 2025.
The effective date of appointment of Messrs. Mohamed and Burns is April 15, 2025.
Ray C. Leonard will not stand for reelection at the Annual Meeting as a result of Mr. Leonard’s decision to retire from the Board at the end of his current term.
elected Paul Giovacchini to the Board to fill the vacancy created by such increase, effective April 21, 2025.
On April 15, 2025, Mr. Sanford Litvack resigned from our Board of Directors, and from the Audit and Compensation Committees on which he served.
Effective April 18, 2025, Ben Hansel resigned as a director of Totaligent, Inc. (the “Company”).
Effective April 18, 2025, the Board of Directors of the Company elected Brian Heckathorne to serve as a director.
On April 15, 2025, Ms. Stephanie Reed notified the Board of Directors (the “Board”) of Tamboran Resources Corporation (the “Company”) of her intent to resign from the Board effective immediately.
and as a member of the Company’s Board of Directors (the “Board”), effective April 18, 2025.
the Board appointed Robert Susman and Jacob Bauer to fill the vacancies on the Board created by the departure of each of Dr. Salzmann and Mr. Migausky
the Board appointed Robert Susman and Jacob Bauer to fill the vacancies on the Board created by the departure of each of Dr. Salzmann and Mr. Migausky
On April 18, 2025, George Migausky, a member of Immunovant’s Board and Chair of the Audit Committee of the Board (the “Audit Committee”), resigned from the Board and the Audit Committee, effective immediately.
the Board appointed Steven C. Crouse and Philip J. Gotwals, Ph.D. to the Board
the Board appointed Steven C. Crouse and Philip J. Gotwals, Ph.D. to the Board
On April 21, 2025, the Board of Directors (the "Board") of Rivian Automotive, Inc. (the "Company") increased the size of the Board and elected Aidan Gomez to serve as a Class II director of the Company with a term expiring at the 2026 annual meeting of stockholders, effective immediately.
On April 18, 2025, Mr. Greg Petersen resigned as a member of the Board. Mr. Petersen informed the Company that his resignation was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
On April 18, 2025, the Board of Directors (the “Board”) of Plus Therapeutics, Inc (the “Company”) unanimously appointed Mr. Kyle Guse to serve as a director of the Board, effective immediately.
Robert Hofmeister, Ph.D. Resignation On April 15, 2025, Dr. Hofmeister resigned as a member of the board of directors (the “Board”) of Alaunos Therapeutics, Inc. (the “Company”) with immediate effect.
On April 4, 2025, the Board of Directors of the Company voted unanimously to appoint Eric Maire to the Board as an Independent Director.
On April 15, 2025, Robert E. Knowling Jr. notified the Board of Directors (the “Board”) of Stride, Inc. (the “Company”) of his decision to resign from the Board and all committees on which he served, effective immediately.
On April 17, 2025, Mr. Fraser notified the Windtree Therapeutics, Inc.(the “ Company ”) Board of Directors (the “ Board ”) of his resignation from the Board, effective immediately.
On April 18, 2025, Vera Bradley, Inc. (the “Company”) announced that long-time board member Frances P. Philip will not stand for re-election at the upcoming 2025 Shareholder Meeting.
The Board of Directors of Juniata Valley Financial Corp. (the “Company”) appointed John Henry IV as a director of the Company on April 15, 2025.
On April 15, 2025,Dexter Fowler and Jennifer Prince notified the Board of Directors (the “Board”) of System1, Inc. (the “Company”) of their respective resignation from the Board, effective as of the close of business on April 15, 2025.
On April 15, 2025,Dexter Fowler and Jennifer Prince notified the Board of Directors (the “Board”) of System1, Inc. (the “Company”) of their respective resignation from the Board, effective as of the close of business on April 15, 2025.
On April 17, 2025, a new independent director was appointed as member of the Board of Directors (the “Board”) of Alixo-Yolloo Corporation (the “Company”).
On April 15, 2025, Messrs. William C. Mulligan and Edward K. Zinser announced their intention to not stand for re-election at the 2026 Annual Meeting.
On April 15, 2025, the Board of Directors (the “Board”) of Universal Electronics Inc. (“UEI” or the “Company”) appointed John Mutch as a director, effective immediately, to fill a vacancy.
On April 15, 2025, Messrs. William C. Mulligan and Edward K. Zinser announced their intention to not stand for re-election at the 2026 Annual Meeting.
Mr. Gary Cohn will serve as Lead Independent Director of the Board of Directors (the “Board”) of Apollo Global Management, Inc. (“AGM”), effective as of April 21, 2025
On April 16, 2025, Richard Parisi and Elizabeth LaPuma delivered notice to the board of directors (the “Board”) of ContextLogic Inc. (the “Company”) of their resignation as directors, effective immediately, to pursue other opportunities.
On April 16, 2025, Richard Parisi and Elizabeth LaPuma delivered notice to the board of directors (the “Board”) of ContextLogic Inc. (the “Company”) of their resignation as directors, effective immediately, to pursue other opportunities.
On April 16, 2025, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, the Board appointed Michael Grissinger to the Board, effective as of April 17, 2025, to fill the vacancy resulting from Dr. Gordon’s resignation.
On April 14, 2025, Carl L. Gordon, Ph.D., a Class II member of the board of directors (the “Board”) of Adicet Bio, Inc. (the “Company”), notified the Company of his resignation from the Board and Compensation Committee of the Board (the “Compensation Committee”), effective on April 17, 2025.
On April 11, 2025, D. Gary Gilliland, M.D., Ph.D., a member of the board of directors (the “Board”) of Nuvalent, Inc. (the “Company”), notified the Company of his decision to resign from the Board and from all committees of the Board on which he serves, effective as of the date and time of the Company’s 2025 annual meeting of stockholders.
On April 11, 2025, Timothy Haley informed the Company of his decision to not stand for re-election as a director at the Company’s 2025 annual meeting of stockholders (the “Annual Meeting”).
Current director Jennifer Banner will not stand for re-election at, and her current term as a director will end, at the Annual Meeting.
On April 16, 2025, the Board, on the recommendation of the Governance Committee of the Board, nominated Harold Zeitz for election to the Board as an independent director at the 2025 annual meeting of stockholders.
On April 14, 2025, Gary P. Fayard, currently a director on the Board of Directors (the “Board”) of Monster Beverage Corporation (the “Company”), provided notice to the Board and management of the Company of his intention not to stand for reelection at the 2025 Annual Meeting of the Stockholders (the “2025 Annual Meeting”).
On April 16, 2025, the Board appointed Howard H. Berman, Ph.D. as a Class III director of the Company, effective at the Effective Time.
In addition, on April 16, 2025, in connection with the Agreement, Franklin Berger informed the Board that he would retire following the end of his current term as a Class I director at the 2027 Annual Meeting.
each member of the board of directors of the Company, other than Donald J. Zurbay, ceased serving in such capacity and accordingly John D. Buck, Meenu Agarwal, Alex N. Blanco, Jody H. Feragen, Robert C. Frenzel, Philip G.J. McKoy, Neil A. Schrimsher, and Pamela J. Tomczik resigned as directors of the Company.
each member of the board of directors of the Company, other than Donald J. Zurbay, ceased serving in such capacity and accordingly John D. Buck, Meenu Agarwal, Alex N. Blanco, Jody H. Feragen, Robert C. Frenzel, Philip G.J. McKoy, Neil A. Schrimsher, and Pamela J. Tomczik resigned as directors of the Company.
each member of the board of directors of the Company, other than Donald J. Zurbay, ceased serving in such capacity and accordingly John D. Buck, Meenu Agarwal, Alex N. Blanco, Jody H. Feragen, Robert C. Frenzel, Philip G.J. McKoy, Neil A. Schrimsher, and Pamela J. Tomczik resigned as directors of the Company.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.